From Raquel Martins, President of Abranghe - Angioedema Hereditário Brasil, HAE International has received the very good news that Takhzyro (Lanadelumab) is now approved in Brazil for the treatment of HAE. The approval comes from the Brazilian Health Regulatory Agency (Anvisa), the coordinator of the Brazilian Health Regulatory System. 25-28 September 2019 Abranghe participated in and promoted HAE at the XLVI Brazilian [...]
24 August 2019 the second Takeda Expert Meeting in HAE took place in Vitória. During the event, doctors interested in HAE from all over Brazil and HAE specialists from several reference centers discussed topics related to the disease. This expert meeting aimed to raise awareness and train doctors on HAE. The HAE International map has been updated with fresh information on [...]
The first half of 2019 has been pretty busy for HAE Brazil (ABRANGHE). The calendar of the three months includes the signing of an access program in Sao Paulo, meetings on rare diseases in Rio de Janeiro and Sao Paulo, another talk in Bom Despacho, and a presentation for doctors in Brasilia. ABRANGHE organized a number of events all over [...]
HAE International is a global non-profit network of member organizations dedicated to raising awareness of hereditary angioedema and improving the lives of people with HAE.
HAE International (HAEi)
10560 Main Street, Ste PS40
Fairfax City, VA 22030
United States of America
gro.ieah@ofni
HAE International (HAEi)
Vejlevej 16, 1.
8700 Horsens
Denmark
gro.ieah@ofni
